CDT Equity Inc. announced a 1-for-10 reverse stock split to ensure continued compliance with the Nasdaq bid-price rule. The split becomes effective on July 17, 2026, and the company's common stock is expected to begin trading on a reverse stock split-adjusted basis on July 20, 2026. CDT Equity Inc. is a data-driven biopharmaceutical development company focused on therapeutic asset advancement through scientific innovation and strategic partnerships.

CDT Equity Inc. entered into an Amended and Restated Loan Agreement and an Amended and Restated Senior Secured Convertible Promissory Note with J.J. Astor & Co. to close the second tranche of a $1,971,000 loan. The company will begin making twenty-four equal weekly installment payments of $82,125 starting July 10, 2026. CDT Equity Inc. is a financial services company.